Overview
- Legal name
- CELLSIGHT TECHNOLOGIES, INC.
- Also known as
- CELLSIGHT TECHNOLOGIES INC
- Registered location
- SAN FRANCISCO, CA, USA
- Website
- Company website ↗
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Sep 15, 2025
Read company summary
CELLSIGHT TECHNOLOGIES, INC. is associated with UEI E3UQXACGFR43 and CAGE 5T0V1 in public federal records. AcornBids currently links 1 prime award totaling $2.0M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists SAN FRANCISCO, CA, USA.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 17, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- CELLSIGHT TECHNOLOGIES, INC.
- Doing business as
- CELLSIGHT TECHNOLOGIES INC
- UEI
- E3UQXACGFR43
- CAGE
- 5T0V1
- Registered address
- 185 BERRY ST, SAN FRANCISCO, CA, 94107, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Sep 13, 2025
- Initial registration
- Nov 20, 2009
- Entity start
- Oct 31, 2007
- SAM updated
- Sep 13, 2025
- Registration expires
- Sep 9, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Research brief
Source facts
- Loaded prime-award records link 1 awards and $1,995,174 in reported obligations to this legal entity. Source
- Recorded awards include Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (NAICS 541715); this classification is not proof of every company capability. Source
- An example award describes: SBIR PHASE II - TOPIC 396 - IMAGING FOR CANCER IMMUNOTHERAPIES Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Histories follow awards currently assigned to this recipient and may include transactions under an earlier recipient. Coverage: 1 of 1 selected awards. Select a period to explore its awards.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | Not reported |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $0 |
| Change | Not reported |
| Growth | Not comparable |
Where the work is performed
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Health and Human Services | $2.0M | 1 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| NIH NCI | $2.0M | 1 |
Naics
| Category | Period obligations | Awards |
|---|---|---|
| 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | $2.0M | 1 |
Psc
| Category | Period obligations | Awards |
|---|---|---|
| AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $2.0M | 1 |
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| Unclassified | $2.0M | 1 |
States
| Category | Period obligations | Awards |
|---|---|---|
| CA | $2.0M | 1 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| SMALL BUSINESS SET ASIDE - TOTAL | $2.0M | 1 |
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N91022C00015SBIR PHASE II - TOPIC 396 - IMAGING FOR CANCER IMMUNOTHERAPIES | Department of Health and Human Services | $2.0M | Sep 16, 2022 | Sep 15, 2026 |
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Sep 13, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Nov 20, 2009 |
| Entity start | Oct 31, 2007 |
Registration classifications: Woman Owned Small Business, Woman Owned Business, Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| SAMUEL QUEZADA | Government business | Contact method not published | SAM registration | Not available |
| JELENA LEVI | Alternate government business | Contact method not published | SAM registration | Not available |
| SAMUEL QUEZADA | Electronic business | Contact method not published | SAM registration | Not available |
| SAMUEL QUEZADA | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit